RPID vs PACB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

RPID

58.9
AI Score
VS
RPID Wins

PACB

38.2
AI Score

Investment Advisor Scores

RPID

59score
Recommendation
STRONG BUY

PACB

38score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric RPID PACB Winner
Forward P/E 0 0 Tie
PEG Ratio 0 -0.17 Tie
Revenue Growth 10.9% 5.5% RPID
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 58.9/100 38.2/100 RPID
Profit Margin -145.6% -81.3% PACB
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY AVOID NEW MONEY RPID

Relative Price Performance (Last 90 Days)

RPID 1M: -14.2% · 3M: -55.9% PACB 1M: +5.5% · 3M: +88.1%

Current Technical Phase

RPID

Markdown
Sell / avoid

Price below a falling SMA50 (slope -28.3%), weak momentum, RSI 41

RSI (14): 41.4 · Price: $0.75

PACB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.7 · Price: $2.16

Fundamentals Snapshot

Metric RPID PACB
Market Cap — —
Forward P/E -1.1 -5.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.1% 0.3%
Operating Margin -1.5% -0.9%
EPS -1.11 -0.42
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, RPID is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.